Biofrontera, Inc. (BFRI)
1.53
-0.03
(-1.92%)
USD |
NASDAQ |
Sep 09, 16:00
1.54
+0.01
(+0.65%)
After-Hours: 16:28
Biofrontera Shareholders Equity (Quarterly) : 5.956M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.956M |
| March 31, 2026 | 6.07M |
| December 31, 2025 | 10.48M |
| September 30, 2025 | -2.581M |
| June 30, 2025 | -4.668M |
| March 31, 2025 | 0.469M |
| December 31, 2024 | 4.433M |
| September 30, 2024 | 5.53M |
| June 30, 2024 | 10.91M |
| March 31, 2024 | -5.416M |
| December 31, 2023 | 4.793M |
| Date | Value |
|---|---|
| September 30, 2023 | 1.038M |
| June 30, 2023 | 7.173M |
| March 31, 2023 | 16.75M |
| December 31, 2022 | 23.88M |
| September 30, 2022 | 22.60M |
| June 30, 2022 | 17.23M |
| March 31, 2022 | 17.42M |
| December 31, 2021 | 11.34M |
| September 30, 2021 | -17.38M |
| June 30, 2021 | -1.367M |
| March 31, 2021 | 2.294M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.06M |
| Total Liabilities (Quarterly) | 18.11M |
| Debt to Equity Ratio | 1.260 |
| Current Ratio | 1.180 |
| Net Debt Paydown Yield | -3.93% |